Matches in Nanopublications for { ?s ?p "[Combined, these findings define a novel transcriptional network regulating oncogenic EGFR signaling and identify a class of FDA-approved drugs as capable of restoring chemosensitivity to anti-EGFR-based therapy for the treatment of metastatic lung adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP633539.RApfYUKkglKebP8V3TBj5Pl6CUTv4JU6OTFcstZG9JnJ0130_assertion description "[Combined, these findings define a novel transcriptional network regulating oncogenic EGFR signaling and identify a class of FDA-approved drugs as capable of restoring chemosensitivity to anti-EGFR-based therapy for the treatment of metastatic lung adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP633539.RApfYUKkglKebP8V3TBj5Pl6CUTv4JU6OTFcstZG9JnJ0130_provenance.
- assertion description "[Combined, these findings define a novel transcriptional network regulating oncogenic EGFR signaling and identify a class of FDA-approved drugs as capable of restoring chemosensitivity to anti-EGFR-based therapy for the treatment of metastatic lung adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP370204.RAYzQ-vZQ_6PGr4AllwBhxMFnYs_yiX7SSkyYXoROnAK0130_assertion description "[Combined, these findings define a novel transcriptional network regulating oncogenic EGFR signaling and identify a class of FDA-approved drugs as capable of restoring chemosensitivity to anti-EGFR-based therapy for the treatment of metastatic lung adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP370204.RAYzQ-vZQ_6PGr4AllwBhxMFnYs_yiX7SSkyYXoROnAK0130_provenance.
- NP986324.RA0OaxOwLfNP9zcR_ESPdM_BrbWn0-TguAxoKdKMaGySw130_assertion description "[Combined, these findings define a novel transcriptional network regulating oncogenic EGFR signaling and identify a class of FDA-approved drugs as capable of restoring chemosensitivity to anti-EGFR-based therapy for the treatment of metastatic lung adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP986324.RA0OaxOwLfNP9zcR_ESPdM_BrbWn0-TguAxoKdKMaGySw130_provenance.